Clidinium Bromide, Chlordiazepoxide & Dicyclomine Tablets 2.5mg+5mg+10mg Technical Specification:
| Product Name: | Clidinium Bromide, Chlordiazepoxide & Dicyclomine Tablets 2.5mg+5mg+10mg |
| Brand Name: | Generics |
| Strength: | (2.5mg+5mg+10mg) |
| Dosage Form: | Tablets (Film-coated) |
| Route of Administration: | Via oral Route |
| Packing: | 10s, 30s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Anticholinergics |
| Indication: | CHLORDIAZEPOXIDE+CLIDINIUM+DICYCLOMINE is a combination medicine used to treat irritable bowel syndrome, peptic ulcers, enterocolitis (swelling in the intestine), and symptoms related to intestinal infection. It effectively solves the related issues of IBS such as acidity, gas, constipation, and much more. |
| Storage: | Store in cool, dry and dark place. At a temperature not exceeding 25˚C. Protect from direct sunlight. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Clidinium Bromide, Chlordiazepoxide & Dicyclomine Tablets 2.5mg+5mg+10mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Clidinium Bromide, Chlordiazepoxide & Dicyclomine Tablets 2.5mg+5mg+10mg
Each Film-coated tablet contains:
Chlordiazepoxide I.P.………………5mg
Clidinium Bromide U.S.P.………………2.5mg
Dicyclomine Hydrochloride I.P…………….10mg
Excipients…………………………q.s.
Colours: Brilliant Blue FCF & Tartrazine
THERAPEUTIC INDICATIONS:
CHLORDIAZEPOXIDE+CLIDINIUM+DICYCLOMINE is a combination medicine used to treat irritable bowel syndrome, peptic ulcers, enterocolitis (swelling in the intestine), and symptoms related to intestinal infection. It effectively solves the related issues of IBS such as acidity, gas, constipation, and much more.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H1” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Storage: Store in cool, dry and dark place. At a temperature not exceeding 25˚C. Protect from direct sunlight.
Dosage: As directed by the Physician.
GENERIC NAME OF THE MEDICINAL PRODUCT:
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each Film-coated tablet contains:
Chlordiazepoxide I.P.………………5mg
Clidinium Bromide U.S.P.……………...2.5mg
Dicyclomine Hydrochloride I.P…………….10mg
Excipients…………………………q.s.
Colours: Brilliant Blue FCF & Tartrazine
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H1” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Dosage: As directed by the Physician.

